Associations of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use with Colorectal Cancer Risk in the Women's Health Initiative | Citedby Results | Cancer Epidemiology, Biomarkers & Prevention | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

Associations of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use with Colorectal Cancer Risk in the Women's Health Initiative

Cancer Epidemiol Biomarkers Prev (2021) 30 (5): 1029–1032.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Advanced progress of the relationship between renin–angiotensin–aldosterone system inhibitors and cancers

Ruixing Zhang
Hongtao Yin
Mengdi Yang
Jinjin Liu
Donghu Zhen
Zheng Zhang

Journal of Hypertension (2024) 42 (11): 1862.

Thiazide Diuretics and Risk of Colorectal Cancer: A Population-Based Cohort Study

Julie Rouette
Emily G McDonald
Tibor Schuster
Ilan Matok
James M Brophy
Laurent Azoulay

American Journal of Epidemiology (2024) 193 (1): 47.

Pharmaceutical Agents as Potential Drivers in the Development of Early-Onset Colorectal Cancer: Case-Control Study

Irit Ben-Aharon
Ran Rotem
Cheli Melzer-Cohen
Gilad Twig
Andrea Cercek
Elizabeth Half
Tal Goshen-Lago
Gabriel Chodik
David Kelsen

JMIR Public Health and Surveillance (2023) 9: e50110.

Long-term use of antihypertensive medications, hypertension and colorectal cancer risk and mortality: a prospective cohort study

Yin Zhang
Mingyang Song
Andrew T. Chan
Jeffrey A. Meyerhardt
Walter C. Willett
Edward L. Giovannucci

British Journal of Cancer (2022) 127 (11): 1974.

Effects of Antihypertensive Drugs Use on Risk and Prognosis of Colorectal Cancer: A Meta-Analysis of 37 Observational Studies

Yujiao Deng
Yuxiu Xie
Meng Wang
Peng Xu
Bajin Wei
Na Li
Ying Wu
Si Yang
Linghui Zhou
Qian Hao
Lijuan Lyu
Dai Zhang
Zhijun Dai

Frontiers in Pharmacology (2022) 12